REDUCED PLATELET CYTOCHROME-C-OXIDASE ACTIVITY IN ALZHEIMERS-DISEASE

被引:186
作者
PARKER, WD
MAHR, NJ
FILLEY, CM
PARKS, JK
HUGHES, D
YOUNG, DA
CULLUM, CM
机构
[1] UNIV COLORADO, SCH MED, DEPT NEUROL, DENVER, CO USA
[2] UNIV COLORADO, SCH MED, DEPT PEDIAT, DENVER, CO USA
[3] UNIV COLORADO, SCH MED, DEPT PREVENT MED & BIOMETR, DENVER, CO USA
[4] UNIV COLORADO, SCH MED, DEPT PSYCHIAT, DENVER, CO 80262 USA
关键词
D O I
10.1212/WNL.44.6.1086
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We evaluated a simplified method for preparation and analysis of platelet cytochrome c oxidase activity in Alzheimer's disease (AD) and control patients. Mean cytochrome c oxidase activity in controls (n = 17) was 0.233 sec(-1)/mg whereas mean cytochrome c oxidase activity in Alzheimer patients (n = 19) was 0.193 sec(-1)/mg, p = 0.033. Complex III (ubiquinol:cytochrome c oxidoreductase), complex II (succinic dehydrogenase), and citrate synthase were all assayed as internal controls and were not significantly different in controls and Alzheimer patients. There is a relatively specific loss of platelet cytochrome c oxidase activity in Alzheimer disease patients.
引用
收藏
页码:1086 / 1090
页数:5
相关论文
共 38 条
[1]   OXIDATIVE-METABOLISM OF CORD BLOOD NEUTROPHILS - RELATIONSHIP TO CONTENT AND DE-GRANULATION OF CYTOPLASMIC GRANULES [J].
AMBRUSO, DR ;
BENTWOOD, B ;
HENSON, PM ;
JOHNSTON, RB .
PEDIATRIC RESEARCH, 1984, 18 (11) :1148-1153
[2]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[3]   ELECTRON-TRANSFER COMPLEX-I DEFECT IN IDIOPATHIC DYSTONIA [J].
BENECKE, R ;
STRUMPER, P ;
WEISS, H .
ANNALS OF NEUROLOGY, 1992, 32 (05) :683-686
[4]  
Bennett M C, 1992, J Geriatr Psychiatry Neurol, V5, P93
[5]   RESPIRATORY-CHAIN ABNORMALITIES IN SKELETAL-MUSCLE FROM PATIENTS WITH PARKINSONS-DISEASE [J].
BINDOFF, LA ;
BIRCHMACHIN, MA ;
CARTLIDGE, NEF ;
PARKER, WD ;
TURNBULL, DM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 104 (02) :203-208
[6]   MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE [J].
BINDOFF, LA ;
BIRCHMACHIN, M ;
CARTLIDGE, NEF ;
PARKER, WD ;
TURNBULL, DM .
LANCET, 1989, 2 (8653) :49-49
[7]  
BLASS JP, 1991, REV NEUROL, V147, P513
[8]  
BLASS JP, 1988, REV NEUROL, V144, P543
[9]  
BLASSE JP, 1990, ARCH NEUROL-CHICAGO, V47, P564
[10]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517